Endeavor

FDA Approval Marks New Era for Pancreatic Cancer Treatment

First-in-class targeted therapy nearly doubles median overall survival for patients with metastatic pancreatic cancer

FDA Approves Rusfertide, Offering a New Option for Polycythemia Vera

For Danielle Sweet, the weekly injection helped end nearly four years of exhausting phlebotomy

Dolly Parton’s Death Shines Light on the Power of Clinical Trials

Her sister’s tribute revealed Dolly’s wish to help future cancer patients

FDA Approves New Approach to Stem Cell Transplants

Roxanne Laveau’s participation in a clinical trial helped lead to the FDA approval of the Orca-T cell therapy for transplant in patients with blood cancers

A Father’s Strength, a Daughter’s Purpose

Watching her dad battle blood cancer inspired Brianna Pratts to pursue a career in cancer care

Two Phase 3 Trials Show New Treatment Paths for Different Non-Small Cell Lung Cancer Types

Selpercatinib lowers recurrence after surgery for RET fusion tumors; ivonescimab extends survival in advanced squamous disease

Could Adding a Targeted Therapy Before Surgery Change Prostate Cancer Care?

Phase 3 trial suggests apalutamide with hormone therapy and surgery extends time before high risk prostate cancer returns or spreads

How One Moffitt Team Is Using AI To Help Decode Cancer Care

ECHO is designed to help researchers connect complex cancer data faster while keeping human expertise at the center of every decision

Targeted Therapy Could Help Patients With Rare Bone Marrow Cancer

Phase 2 study presented at ASCO finds symptom and spleen improvements for patients with limited options